PhaseBio Pharmaceuticals, Inc. (PHAS)

Income Before Tax

$26.50M

TTM · Period ending: · USD

PHAS logo

PHAS Income Before Tax

Latest reported$26.50M
PHAS Pre-Tax Income (-$9.22M → $26.50M)
High-resolution chart · PNG

PHAS income before tax history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

PhaseBio Pharmaceuticals, Inc. Income Before Tax — Annual fiscal periods (USD)
Period endingIncome Before Tax (USD)
-129,471
-98,565,000
-39,247,000
-23,846,000
-10,247,000
-9,220,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.